Journal of Medical and Pharmaceutical Innovation

10.15272/jmpi ◽  
2015 ◽  
Keyword(s):  
Pharmaceutical Innovation

scholarly journals Schrödinger’s pipeline and the outsourcing of pharmaceutical innovation

2020 ◽  
Vol 25 (3) ◽  
pp. 480-484 ◽  
Author(s):  
Peter McMeekin ◽  
Dennis W. Lendrem ◽  
B. Clare Lendrem ◽  
Arthur G. Pratt ◽  
Richard Peck ◽  
...  
Keyword(s):  
Pharmaceutical Innovation

Identifying and Rewarding Pharmaceutical Innovation: Application in an EU Member State

2010 ◽  
Vol 44 (3) ◽  
pp. 317-323 ◽  
Author(s):  
Philippe Van Wilder ◽  
Qi Zhu ◽  
Noël Veraverbeke
Keyword(s):  
Member State ◽  
Pharmaceutical Innovation

How pharmaceutical innovation evolves: The path from science to technological development to marketable drugs

2021 ◽  
Vol 167 ◽  
pp. 120698
Author(s):  
Xuefeng Wang ◽  
Shuo Zhang ◽  
Yuqin Liu ◽  
Jian Du ◽  
Heng Huang
Keyword(s):  
Technological Development ◽  
Pharmaceutical Innovation

scholarly journals Could Globalisation be Good for World Health?

1970 ◽  
Vol 1 ◽  
Author(s):  
Thomas Pogge
Keyword(s):  
Disease Burden ◽  
Pharmaceutical Innovation ◽  
World Health ◽  
Medical Treatments ◽  
Alternative Scheme ◽  
International Patent ◽  
Good For ◽  
The Impact ◽  
Perverse Effect ◽  
Global Disease Burden

Every day thousands of people die from poverty-related causes. Many of these deaths could be avoided if appropriate medical treatments were available to the world’s poor. Due to the current tructure of the international patent regime, they are not. Since the risks and costs associated with pharmaceutical innovation are extremely high, to incentivise research, inventor firms are granted a temporary monopoly over newly invented drugs. While allowing firms to make up for the costs of research, this has the morally perverse effect of raising the prices of pharmaceuticals to a level where they become unaffordable to the world’s poor. To correct this grievous flaw, the paper proposes a concrete and realistic alternative scheme which, by rewarding medical innovators in proportion to the impact of their drugs on the global disease burden, would incentivise the production and selling of crucial drugs for the world’s poor at prices accessible to them.

Sign in / Sign up

Export Citation Format

Share Document